Medical Journal Lancet issues correction on study of COVID-19 and hydroxychloroquine trial The study published by on Lancet May 22 led the WHO to temporarily suspend the trial of HCQ on COVID-19 patients.The Lancet is among the many signatories to a statement on data sharing for COVID-19 studies
The study published by on Lancet May 22 led the WHO to temporarily suspend the trial of HCQ on COVID-19 patients.The Lancet is among the many signatories to a statement on data sharing for COVID-19 studies
from Livemint - Science https://ift.tt/3dlTLkA
https://ift.tt/eA8V8J
from Livemint - Science https://ift.tt/3dlTLkA
https://ift.tt/eA8V8J
Comments
Post a Comment